Rochester, Minn.-based Mayo Clinic, Hibiscus BioVentures and Innoforce have launched a cell and gene therapy accelerator aimed at identifying and forming companies around technologies that address unmet patient needs.
Read the full post on Becker's Hospital Review - Healthcare News
